Literature DB >> 17058109

Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris.

Huaiyu Zhou1, Qinmin Gu, Qunli Zhao, Jiaqin Zhang, Hua Cong, Ying Li, Shenyi He.   

Abstract

Toxoplasma gondii is an obligate intracellular protozoan which infects most species of warm-blooded animals and causes toxoplasmosis. Previous immunological and immunization studies have demonstrated the potential role of T. gondii antigens SAG1 and GRA2 as a vaccine candidate. In the present study, we have cloned, expressed, and purified a recombinant protein SAG1-GRA2 in Pichia pastoris. Results showed that P. pastoris was a robust system producing a large amount of highly purified and biological activity protein. BALB/c mice immunized with SAG1-GRA2 elicited stronger humoral and cellular responses in comparison to control groups. This immunization resulted in an enhanced Th1 immune response as measured by IgG2a antibody production and increased splenocyte IFN-gamma production, whereas no IL-4 was detected. After a lethal challenge with the highly virulent T. gondii RH strain, a prolonged survival time in SAG1-GRA2-immunized mice was observed in comparison to control groups. Our data demonstrate that SAG1-GRA2 triggered a protective response against toxoplasmosis. Therefore, SAG1-GRA2 protein might be a good candidate for the further development of a multiantigenic vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058109     DOI: 10.1007/s00436-006-0341-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  30 in total

1.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris.

Authors:  K Sreekrishna; R G Brankamp; K E Kropp; D T Blankenship; J T Tsay; P L Smith; J D Wierschke; A Subramaniam; L A Birkenberger
Journal:  Gene       Date:  1997-04-29       Impact factor: 3.688

3.  Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii.

Authors:  S D Sharma; F G Araujo; J S Remington
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

Review 4.  Heterologous protein production using the Pichia pastoris expression system.

Authors:  Sue Macauley-Patrick; Mariana L Fazenda; Brian McNeil; Linda M Harvey
Journal:  Yeast       Date:  2005-03       Impact factor: 3.239

5.  Vaccination of mice with the protective F3G3 antigen of Toxoplasma gondii activates CD4+ but not CD8+ T cells and induces Toxoplasma specific IgG antibody.

Authors:  V Brinkmann; J S Remington; S D Sharma
Journal:  Mol Immunol       Date:  1993-03       Impact factor: 4.407

6.  Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.

Authors:  E Petersen; H V Nielsen; L Christiansen; J Spenter
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

7.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

8.  Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant.

Authors:  D Buxton; K Thomson; S Maley; S Wright; H J Bos
Journal:  Vet Rec       Date:  1991-08-03       Impact factor: 2.695

9.  Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control.

Authors:  J M Kowalski; R N Parekh; J Mao; K D Wittrup
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

Review 10.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

View more
  15 in total

1.  Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Xiao Teng Ching; Mun Yik Fong; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Vaccines against Toxoplasma gondii: status, challenges and future directions.

Authors:  Qi Liu; Lachhman Das Singla; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

3.  Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.

Authors:  Hira Ram; J R Rao; A K Tewari; P S Banerjee; A K Sharma
Journal:  Parasitol Res       Date:  2013-04-10       Impact factor: 2.289

4.  Evaluation of Toxoplasma gondii-recombinant dense granular protein (GRA2) for serodiagnosis by western blot.

Authors:  Xiao Teng Ching; Yee Ling Lau; Mun Yik Fong; Veeranoot Nissapatorn
Journal:  Parasitol Res       Date:  2012-12-29       Impact factor: 2.289

5.  Immunogenic characterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris.

Authors:  Yee Ling Lau; Girija Thiruvengadam; Wei Wei Lee; Mun Yik Fong
Journal:  Parasitol Res       Date:  2011-04-01       Impact factor: 2.289

6.  Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.

Authors:  Zi-Guo Yuan; Xiu-Xiang Zhang; Xian-Hui He; Eskild Petersen; Dong-Hui Zhou; Yong He; Rui-Qing Lin; Xiu-Zhen Li; Xu-Li Chen; Xiao-Ru Shi; Xiu-Ling Zhong; Bing Zhang; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

7.  Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice.

Authors:  Melina Laguía-Becher; Valentina Martín; Mauricio Kraemer; Mariana Corigliano; María L Yacono; Alejandra Goldman; Marina Clemente
Journal:  BMC Biotechnol       Date:  2010-07-15       Impact factor: 2.563

8.  Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice.

Authors:  Daofeng Qu; Jianzhong Han; Aifang Du
Journal:  Parasitol Res       Date:  2013-04-17       Impact factor: 2.289

Review 9.  Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies.

Authors:  Lucyna Holec-Gasior
Journal:  Clin Vaccine Immunol       Date:  2013-06-19

10.  Recombinant SAG1 Antigen to Detect Toxoplasma gondii Specific Immunoglobulin G in Human Sera by ELISA Test.

Authors:  N Jalallou; M Bandepour; H Khazan; A Haghighi; Sh Abdollahi; B Kazemi
Journal:  Iran J Parasitol       Date:  2010-06       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.